Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Cash from Investing Activities: 2017-2021

Historic Cash from Investing Activities for Cogent Biosciences (COGT) over the last 3 years, with Dec 2021 value amounting to -$433,000.

  • Cogent Biosciences' Cash from Investing Activities was N/A to -$433,000 in Q4 2021 from the same period last year, while for Dec 2021 it was -$1.4 million, marking a year-over-year change of. This contributed to the annual value of $38.3 million for FY2024, which is 139.13% up from last year.
  • According to the latest figures from Q4 2021, Cogent Biosciences' Cash from Investing Activities is -$433,000, which was up 62.77% from -$1.2 million recorded in Q3 2021.
  • In the past 5 years, Cogent Biosciences' Cash from Investing Activities registered a high of $15.0 million during Q4 2018, and its lowest value of -$41.4 million during Q2 2018.
  • In the last 2 years, Cogent Biosciences' Cash from Investing Activities had a median value of $106,500 in 2019 and averaged $3.6 million.
  • Data for Cogent Biosciences' Cash from Investing Activities shows a peak YoY increase of 822.56% (in 2018) and a maximum YoY decrease of 1,193.58% (in 2018) over the last 5 years.
  • Over the past 4 years, Cogent Biosciences' Cash from Investing Activities (Quarterly) stood at $4.9 million in 2017, then spiked by 206.12% to $15.0 million in 2018, then tumbled by 100.09% to -$13,000 in 2019, then reached -$433,000 in 2021.
  • Its Cash from Investing Activities was -$433,000 in Q4 2021, compared to -$1.2 million in Q3 2021 and -$13,000 in Q4 2019.